• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接种 COVID-19 疫苗的 1969-1989 年出生队列中实施 HCV 筛查。

Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination.

机构信息

Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

ASST Fatebenefratelli-Sacco, First Division of Infectious Diseases, Milan, Italy.

出版信息

Liver Int. 2022 May;42(5):1012-1016. doi: 10.1111/liv.15216. Epub 2022 Mar 12.

DOI:10.1111/liv.15216
PMID:35220667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9115160/
Abstract

BACKGROUND AND AIM

The World Health Organization (WHO) goal of hepatitis C virus (HCV) elimination by 2030 relies on the scaling-up of both identification and linkage to care of the infected population, worldwide. In Italy, the estimated burden of HCV carriers who are unaware of their infection amounts to 200 000 persons, a projection that reinforces the need for broadening population access to effective screening programmes.

METHODS

A pivotal screening programme targeting subjects born between 1969 and 1989 has been conducted in Lombardy, Northern Italy, where point-of-care (POC) testing was offered for free concomitantly to COVID-19 vaccination.

RESULTS

Amongst 7219 subjects born between 1969 and 1989 who underwent HCV screening through POC, 7 (0.10%) subjects tested anti-HCV positive: 5 (0.07%) had confirmed anti-HCV positivity (Table 1) and 4 of them (0.05%) were HCV-RNA positive by standard confirmation tests.

CONCLUSIONS

This pivotal study demonstrated the feasibility of a POC-based anti-HCV screening programme in young adults undergoing COVID-19 vaccination. The prevalence of HCV infection in subjects born in the 1969-1989 cohort in Italy seems to be lower than previously estimated. Whether the extension of this programme to subjects born before 1969 could lead to improved screening effectiveness should be a matter of debate.

摘要

背景与目的

世界卫生组织(WHO)的目标是在 2030 年前消除丙型肝炎病毒(HCV),这依赖于全球范围内扩大对受感染人群的发现和联系,以提供治疗。在意大利,估计有 20 万 HCV 携带者不知道自己被感染,这一预测加强了扩大人群获得有效筛查计划的必要性。

方法

意大利北部伦巴第大区开展了一项针对 1969 年至 1989 年出生人群的重要筛查计划,该计划同时为 COVID-19 疫苗接种提供了即时检测(POC)服务。

结果

在接受 POC 筛查的 7219 名 1969 年至 1989 年出生的人群中,有 7 人(0.10%)抗 HCV 检测呈阳性:5 人(0.07%)抗 HCV 阳性确诊(表 1),其中 4 人(0.05%)标准确认试验 HCV-RNA 阳性。

结论

这项重要研究证明了在接受 COVID-19 疫苗接种的年轻人中进行 POC 为基础的抗 HCV 筛查计划的可行性。意大利 1969-1989 年出生人群 HCV 感染的患病率似乎低于之前的估计。将该计划扩大到 1969 年之前出生的人群是否能提高筛查效果,这应该是一个值得讨论的问题。

相似文献

1
Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination.在接种 COVID-19 疫苗的 1969-1989 年出生队列中实施 HCV 筛查。
Liver Int. 2022 May;42(5):1012-1016. doi: 10.1111/liv.15216. Epub 2022 Mar 12.
2
A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969-1989 birth-cohort.意大利北部全地区基于医院的一般人群 HCV 机会性筛查:1969-1989 年出生队列。
Liver Int. 2023 Dec;43(12):2645-2656. doi: 10.1111/liv.15727. Epub 2023 Sep 16.
3
Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.意大利南部消除丙型肝炎:不同医院科室住院患者 HCV 筛查和护理衔接模型。
Viruses. 2022 May 19;14(5):1096. doi: 10.3390/v14051096.
4
Emergency department targeted screening for hepatitis C does not improve linkage to care.急诊科针对丙型肝炎的目标筛查并不能改善与医疗服务的衔接。
World J Gastroenterol. 2020 Aug 28;26(32):4878-4888. doi: 10.3748/wjg.v26.i32.4878.
5
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.意大利实现丙型肝炎病毒(HCV)消除的里程碑:从免费筛查到 HCV 自由国家的区域路线图。
Dig Liver Dis. 2022 Feb;54(2):237-242. doi: 10.1016/j.dld.2021.03.026. Epub 2021 Apr 27.
6
Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.加拿大急诊部对高危患者进行丙型肝炎病毒筛查。
Can J Gastroenterol Hepatol. 2020 Feb 17;2020:5258289. doi: 10.1155/2020/5258289. eCollection 2020.
7
Emergency department testing is feasible but ineffective to eliminate hepatitis C in Denmark.在丹麦,急诊部门的检测可行但无效,无法消除丙型肝炎。
Infect Dis (Lond). 2021 Nov-Dec;53(12):930-941. doi: 10.1080/23744235.2021.1962542. Epub 2021 Aug 11.
8
Confirmation of guideline-defined hepatitis C screening strategies within the 'Check-Up35+' examination in the primary care setting.在初级保健机构的“35岁以上体检”中对指南定义的丙型肝炎筛查策略进行确认。
Liver Int. 2023 Apr;43(4):785-793. doi: 10.1111/liv.15516. Epub 2023 Jan 13.
9
Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA.降低即时检验读片时间并不影响丙型肝炎病毒检测,且减少了对 RNA 反射检测的需求。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1451-1458.e4. doi: 10.1016/j.cgh.2020.07.058. Epub 2020 Aug 4.
10
Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study.直接准入转诊的床边丙型肝炎筛查提高中途之家居民的护理衔接:一项试点随机研究。
Singapore Med J. 2022 Feb;63(2):86-92. doi: 10.11622/smedj.2020116. Epub 2020 Jul 30.

引用本文的文献

1
Prevalence of Hepatitis C in the Emilia-Romagna Region of Italy: Population-Wide Screening.意大利艾米利亚-罗马涅地区丙型肝炎的患病率:全人群筛查
Viruses. 2025 Jun 12;17(6):843. doi: 10.3390/v17060843.
2
Prevalence of Hepatitis C Virus Among Hospitalized Patients in a Tertiary Hospital in Italy: The Basis for a National Screening Assessment Model?意大利一家三级医院住院患者中丙型肝炎病毒的流行情况:国家筛查评估模型的基础?
Microorganisms. 2025 Jan 10;13(1):129. doi: 10.3390/microorganisms13010129.
3
Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years.消除 HCV 感染:近年流行病学发现、障碍及未来策略。
Viruses. 2024 Nov 19;16(11):1792. doi: 10.3390/v16111792.
4
Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience.全国性 HCV 消除策略需要覆盖一般人群中的老年患者:意大利的经验。
Viruses. 2023 Oct 31;15(11):2199. doi: 10.3390/v15112199.
5
Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain.西班牙对边缘化人群开展的新冠病毒疫苗接种与丙型肝炎病毒筛查联合干预措施
Commun Med (Lond). 2023 May 12;3(1):66. doi: 10.1038/s43856-023-00292-y.
6
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study.Glecaprevir/Pibrentasvir 治疗 8 周在挑战性 HCV 患者中的安全性和有效性:来自 CREST 研究的意大利数据。
PLoS One. 2023 Feb 2;18(2):e0280165. doi: 10.1371/journal.pone.0280165. eCollection 2023.
7
Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection.丙型肝炎病毒(HCV)与新冠病毒病(COVID-19)相关服务的机会性联合筛查:一种需要深入思考的创新性应对措施。
Liver Int. 2022 May;42(5):960-962. doi: 10.1111/liv.15243.

本文引用的文献

1
Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective study.在爱尔兰的一个大城市人群中,对妊娠女性进行常规丙型肝炎筛查具有成本效益:一项回顾性研究。
BJOG. 2022 Jan;129(2):322-327. doi: 10.1111/1471-0528.16984. Epub 2021 Nov 20.
2
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis.意大利通过筛查诊断的患者接受抗 HCV 治疗的经济后果:一项前瞻性建模分析。
Appl Health Econ Health Policy. 2022 Jan;20(1):133-143. doi: 10.1007/s40258-021-00677-x. Epub 2021 Oct 12.
3
Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison.对爱尔兰监狱所有囚犯进行丙型肝炎病毒大规模筛查的成本效益。
Int J Drug Policy. 2021 Oct;96:103394. doi: 10.1016/j.drugpo.2021.103394. Epub 2021 Aug 17.
4
Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey.新冠疫情一年后意大利肝病的管理:一项基于网络的调查。
Liver Int. 2021 Sep;41(9):2228-2232. doi: 10.1111/liv.14998. Epub 2021 Jul 11.
5
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.意大利实现丙型肝炎病毒(HCV)消除的里程碑:从免费筛查到 HCV 自由国家的区域路线图。
Dig Liver Dis. 2022 Feb;54(2):237-242. doi: 10.1016/j.dld.2021.03.026. Epub 2021 Apr 27.
6
Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression.意大利未确诊丙型肝炎病毒感染个体的估计患病率:基于传播途径和纤维化进展的数学模型
Epidemics. 2021 Mar;34:100442. doi: 10.1016/j.epidem.2021.100442. Epub 2021 Feb 11.
7
Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands.荷兰孕妇中丙型肝炎病毒筛查、后续监测或治疗的成本效益。
Eur J Health Econ. 2021 Feb;22(1):75-88. doi: 10.1007/s10198-020-01236-2. Epub 2020 Oct 16.
8
Impact of COVID-19 on global HCV elimination efforts.新冠疫情对全球丙型肝炎病毒消除工作的影响。
J Hepatol. 2021 Jan;74(1):31-36. doi: 10.1016/j.jhep.2020.07.042. Epub 2020 Aug 7.
9
Cost-effectiveness of strategies to improve HCV screening, linkage-to-care and treatment in remand prison settings in England.英格兰还押监狱环境中改善丙型肝炎病毒筛查、护理衔接及治疗策略的成本效益
Liver Int. 2020 Dec;40(12):2950-2960. doi: 10.1111/liv.14628. Epub 2020 Nov 17.
10
Optimization of hepatitis C virus screening strategies by birth cohort in Italy.意大利基于出生队列对丙型肝炎病毒筛查策略的优化。
Liver Int. 2020 Jul;40(7):1545-1555. doi: 10.1111/liv.14408. Epub 2020 Apr 2.